# Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects

> **NCT01033851** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 89 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Mindfulness Based Stress Reduction
- **BEHAVIORAL:** Stress Management Education

## Key facts

- **NCT ID:** NCT01033851
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-01
- **Final completion:** 2013-02
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2014-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033851, "Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01033851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*